RETRACTED: EPCA-2: A Highly Specific Serum Marker for Prostate Cancer
- 1 April 2007
- journal article
- research article
- Published by Elsevier BV in Urology
- Vol. 69 (4), 714-720
- https://doi.org/10.1016/j.urology.2007.01.097
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Autoantibody Signatures in Prostate CancerNew England Journal of Medicine, 2005
- Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per MilliliterNew England Journal of Medicine, 2004
- Detection of Prostate Cancer Using Serum Proteomics Pattern in a Histologically Confirmed PopulationJournal of Urology, 2004
- Confidence Bounds When the Estimated ROC Area is 1.0Academic Radiology, 2002
- Characterization of the nuclear matrix proteins in a transgenic mouse model for prostate cancerJournal of Cellular Biochemistry, 2002
- Delineation of prognostic biomarkers in prostate cancerNature, 2001
- DIFFERENTIAL NUCLEAR MATRIX PROTEIN EXPRESSION IN PROSTATE CANCERS: CORRELATION WITH PATHOLOGIC STAGEJournal of Urology, 1998
- A common set of nuclear matrix proteins in prostate cancer cellsThe Prostate, 1993